Advanced TBI Biomarker Litigation Panel
The Problem
Normal CT/MRI imaging results
Symptoms labeled as “subjective”
Defense IMEs argue malingering
The Solution
Lab-verified neuronal damage (GFAP)
Anchors injury to incident timeline
Validates long-term cognitive impact
Texas 2024–2025 data. Biomarker evidence consistently drives higher valuations across all severity levels.
| Severity | Typical Without Biomarkers | With Biomarkers | Estimated Increase |
|---|---|---|---|
| Mild TBI (Concussion) | $50K – $150K | $200K – $650K+ | +$150K – $500K |
| Moderate TBI | $150K – $500K | $750K – $3M+ | +$600K – $2.5M |
| Severe TBI | $500K – $1.5M | $2M – $10M+ | +$1.5M – $8M+ |
Without
$50K – $150K
With Biomarkers
$200K – $650K+
Increase
+$150K – $500K
Without
$150K – $500K
With Biomarkers
$750K – $3M+
Increase
+$600K – $2.5M
Without
$500K – $1.5M
With Biomarkers
$2M – $10M+
Increase
+$1.5M – $8M+
Counters defense arguments that symptoms are subjective. Validates medical costs ($85K–$3M) even when CT/MRI is negative.
Quantifiable data makes claims compelling to juries. Supports gross negligence claims for punitive damages in Texas.
Justifies extensive future care, rehab ($1,600/day), and lost earning capacity — especially for younger plaintiffs.
Validates pain and suffering (uncapped in Texas PI cases), emotional distress, and post-concussion syndrome.
$4 Million
2024 · Semi-Truck
Advanced diagnostics confirmed severe TBI despite initial disputes.
$1.2 Million
2025 · Car Crash
Rehabilitation costs bolstered by confirmation of injury extent.
$900,000
2025 · Construction
Biomarkers justified disability and vocational retraining costs.
Return on Investment
Panel Cost
$5,500
Recoverable case expense
Potential Uplift
$150K – $2M+
Depending on severity
“This is not a medical test. It is a case value multiplier.”
Defense Challenges
"Normal scan results prove no injury occurred."
Biomarker Counter
Standard CT and MRI cannot detect microscopic axonal or glial damage. Biomarkers measure molecular injury invisible to imaging.
"Symptoms are subjective, coached, or exaggerated."
Biomarker Counter
Blood-based biomarkers provide quantifiable, objective data independent of patient narrative or self-reporting.
"Alternative causes explain the symptoms."
Biomarker Counter
Measurable protein levels specific to neural injury establish a biologic basis that defense experts cannot dismiss.
Forensic & Technical Specifications
Glial Fibrillary Acidic Protein / Ubiquitin C-Terminal Hydrolase
Detects glial and neuronal damage within hours of injury. High sensitivity for CT-negative cases. FDA-approved for mild-to-moderate TBI diagnosis.
Neurofilament Light Chain
Measures axonal injury and ongoing neuronal damage. Correlates directly with chronic neurological impairment and long-term disability.
Identifies genetic variants (e4) with significantly worse recovery trajectories.
Emerging marker linking acute concussion to neurodegenerative risk.
FDA-cleared markers supported by large validation cohorts.
Objective biochemical data shortens disputes over injury validity.
Supports gross negligence claims in unsafe worksite or protocol failure cases.
The Process
Same-week availability across Texas.
FDA-cleared platform testing.
3–4 page mediation-ready analysis.
Criminal Defense
An estimated 50–80% of incarcerated individuals have a history of traumatic brain injury. Objective biomarker evidence can document TBI as a mitigating factor in sentencing, supporting arguments for rehabilitation over incarceration.
Biomarker data provides measurable, biologic evidence of brain injury that can be presented during sentencing hearings — independent of patient narrative, self-reporting, or subjective clinical impressions.
Investment Analysis
Panel Cost
$5,500
100% recoverable expense
Average Case Lift
6.4X
Return on investment
Documented Range
$252K–$4M
Recent Texas settlements
Texas Rule 103/167 Compliance: Diagnostic costs are fully recoverable as necessary litigation expenses. Reports formatted for Daubert/Robinson challenge resistance, ensuring admissibility in both State and Federal courts.
Contact Legal Liaison
Same-week mobile blood draw available across Texas. Reports delivered in 3–4 business days.
© 2026 New World Partners Healthcare. All rights reserved.
